Skip to content

TriSalus Life Sciences, Inc. TLSI Convertible Preferred Stock Authorized Shares

Convertible Preferred Stock Authorized Shares at other companies

InfuSystem Holdings logo
InfuSystem HoldingsINFU
1M0.0%
Delcath Systems logo
Delcath SystemsDCTH
10M0.0%
Nektar Therapeutics logo
Nektar TherapeuticsNKTR
10M0.0%

Other financials

Income statement

See full
Revenue$8.9M-2.9%
Gross profit$7.7M0.0%
Operating income-$8.4M-14.8%
Net income$1.5M+115%
EPS (diluted)$0.03+108%

Balance sheet

See full
Cash & equivalents$56.6M+324%
Total debt$33.1M+4.4%
Total equity$12.8M+137%
Total assets$71.0M+148%

Cash flow

See full
Operating cash flow-$6.5M-44.0%
CapEx$141.0K-81.3%
Free cash flow-$6.6M-26.0%

Valuation

See full
Market cap$279.45M+49.6%
Enterprise value$255.97M+33.6%
P/S6.2×+1.0×

Profitability

See full
Gross margin85.1%-0.5pp
Operating margin-62.4%-16.8pp
Net margin-60.9%-13.4pp
FCF margin-45.2%-16.8pp

Returns & leverage

See full
Return on equity253.3%
Debt / equity2.6×
Current ratio5.8×+3.6×

Where this comes from

Reported directly by TriSalus Life Sciences, Inc. in its filing.

Tagged under the XBRL concept us-gaap:PreferredStockSharesAuthorized.

The official record: TriSalus Life Sciences, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about TriSalus Life Sciences, Inc.'s convertible preferred stock authorized shares.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is TriSalus Life Sciences, Inc.'s convertible preferred stock authorized shares?
TriSalus Life Sciences, Inc. (TLSI) reported convertible preferred stock authorized shares of 10M in Q1 2026.
How has TriSalus Life Sciences, Inc.'s convertible preferred stock authorized shares changed year-over-year?
TriSalus Life Sciences, Inc.'s convertible preferred stock authorized shares decreased by 0.0% year-over-year, from 10M to 10M.
What is the long-term trend for TriSalus Life Sciences, Inc.'s convertible preferred stock authorized shares?
Over 2 years (2023 to 2025), TriSalus Life Sciences, Inc.'s convertible preferred stock authorized shares has grown at a 0.0% compound annual growth rate (CAGR), from 10M to 10M.
What does convertible preferred stock authorized shares mean?
Maximum number of convertible preferred shares the company is authorized to issue under its corporate charter.